Global Brain Tumor Diagnosis and Therapeutics Market Research Report 2023

The global Brain Tumor Diagnosis and Therapeutics market was valued at US$ 624.3 million in 2022 and is anticipated to reach US$ 909.9 million by 2029, witnessing a CAGR of 6.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Brain Tumor Diagnosis and Therapeutics in Surgery is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Brain Tumor Diagnosis and Therapeutics include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnosis and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnosis and Therapeutics.

The Brain Tumor Diagnosis and Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Brain Tumor Diagnosis and Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brain Tumor Diagnosis and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 MRI

1.2.3 CT Scan

1.2.4 Tissue Sampling

1.2.5 PET-CT Scan

1.2.6 Cerebral Arteriogram

1.2.7 Lumbar Puncture

1.2.8 Molecular Testing

1.2.9 EEG

1.3 Market by Application

1.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Surgery

1.3.3 Radiation Therapy

1.3.4 Chemotherapy

1.3.5 Immunotherapy

1.3.6 Targeted Therapy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Brain Tumor Diagnosis and Therapeutics Market Perspective (2018-2029)

2.2 Brain Tumor Diagnosis and Therapeutics Growth Trends by Region

2.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Brain Tumor Diagnosis and Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Brain Tumor Diagnosis and Therapeutics Market Dynamics

2.3.1 Brain Tumor Diagnosis and Therapeutics Industry Trends

2.3.2 Brain Tumor Diagnosis and Therapeutics Market Drivers

2.3.3 Brain Tumor Diagnosis and Therapeutics Market Challenges

2.3.4 Brain Tumor Diagnosis and Therapeutics Market Restraints

3.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue

3.1.1 Global Top Brain Tumor Diagnosis and Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Brain Tumor Diagnosis and Therapeutics Revenue

3.4 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio

3.4.1 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Therapeutics Revenue in 2022

3.5 Brain Tumor Diagnosis and Therapeutics Key Players Head office and Area Served

3.6 Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service

3.7 Date of Enter into Brain Tumor Diagnosis and Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)

6.2 North America Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023)

6.4 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)

7.2 Europe Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023)

7.4 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)

9.2 Latin America Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 GE Healthcare

11.1.1 GE Healthcare Company Detail

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Introduction

11.1.4 GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.1.5 GE Healthcare Recent Development

11.2 Hitachi

11.2.1 Hitachi Company Detail

11.2.2 Hitachi Business Overview

11.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Introduction

11.2.4 Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.2.5 Hitachi Recent Development

11.3 Philips Healthcare

11.3.1 Philips Healthcare Company Detail

11.3.2 Philips Healthcare Business Overview

11.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Introduction

11.3.4 Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.3.5 Philips Healthcare Recent Development

11.4 Siemens Healthineers

11.4.1 Siemens Healthineers Company Detail

11.4.2 Siemens Healthineers Business Overview

11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Introduction

11.4.4 Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.4.5 Siemens Healthineers Recent Development

11.5 Toshiba Corporation

11.5.1 Toshiba Corporation Company Detail

11.5.2 Toshiba Corporation Business Overview

11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Introduction

11.5.4 Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.5.5 Toshiba Corporation Recent Development

11.6 Fujifilm Corporation

11.6.1 Fujifilm Corporation Company Detail

11.6.2 Fujifilm Corporation Business Overview

11.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Introduction

11.6.4 Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.6.5 Fujifilm Corporation Recent Development

11.7 Shimadzu Corporation

11.7.1 Shimadzu Corporation Company Detail

11.7.2 Shimadzu Corporation Business Overview

11.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Introduction

11.7.4 Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.7.5 Shimadzu Corporation Recent Development

11.8 Merck & Co.

11.8.1 Merck & Co. Company Detail

11.8.2 Merck & Co. Business Overview

11.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Introduction

11.8.4 Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.8.5 Merck & Co. Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Detail

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Introduction

11.9.4 AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.9.5 AstraZeneca Recent Development

11.10 Bristol Myer Squibb

11.10.1 Bristol Myer Squibb Company Detail

11.10.2 Bristol Myer Squibb Business Overview

11.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Introduction

11.10.4 Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.10.5 Bristol Myer Squibb Recent Development

11.11 Novartis

11.11.1 Novartis Company Detail

11.11.2 Novartis Business Overview

11.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Introduction

11.11.4 Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.11.5 Novartis Recent Development

11.12 Roche Diagnostics

11.12.1 Roche Diagnostics Company Detail

11.12.2 Roche Diagnostics Business Overview

11.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Introduction

11.12.4 Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

11.12.5 Roche Diagnostics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of MRI

    Table 3. Key Players of CT Scan

    Table 4. Key Players of Tissue Sampling

    Table 5. Key Players of PET-CT Scan

    Table 6. Key Players of Cerebral Arteriogram

    Table 7. Key Players of Lumbar Puncture

    Table 8. Key Players of Molecular Testing

    Table 9. Key Players of EEG

    Table 10. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 12. Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 13. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2018-2023)

    Table 14. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 15. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2024-2029)

    Table 16. Brain Tumor Diagnosis and Therapeutics Market Trends

    Table 17. Brain Tumor Diagnosis and Therapeutics Market Drivers

    Table 18. Brain Tumor Diagnosis and Therapeutics Market Challenges

    Table 19. Brain Tumor Diagnosis and Therapeutics Market Restraints

    Table 20. Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 21. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players (2018-2023)

    Table 22. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2022)

    Table 23. Ranking of Global Top Brain Tumor Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 24. Global 5 Largest Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 25. Key Players Headquarters and Area Served

    Table 26. Key Players Brain Tumor Diagnosis and Therapeutics Product Solution and Service

    Table 27. Date of Enter into Brain Tumor Diagnosis and Therapeutics Market

    Table 28. Mergers & Acquisitions, Expansion Plans

    Table 29. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 30. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2018-2023)

    Table 31. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 32. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2024-2029)

    Table 33. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 34. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2018-2023)

    Table 35. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 36. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Application (2024-2029)

    Table 37. North America Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 39. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Europe Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 45. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 46. Latin America Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 50. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 51. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 52. GE Healthcare Company Detail

    Table 53. GE Healthcare Business Overview

    Table 54. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product

    Table 55. GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 56. GE Healthcare Recent Development

    Table 57. Hitachi Company Detail

    Table 58. Hitachi Business Overview

    Table 59. Hitachi Brain Tumor Diagnosis and Therapeutics Product

    Table 60. Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 61. Hitachi Recent Development

    Table 62. Philips Healthcare Company Detail

    Table 63. Philips Healthcare Business Overview

    Table 64. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product

    Table 65. Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 66. Philips Healthcare Recent Development

    Table 67. Siemens Healthineers Company Detail

    Table 68. Siemens Healthineers Business Overview

    Table 69. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product

    Table 70. Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 71. Siemens Healthineers Recent Development

    Table 72. Toshiba Corporation Company Detail

    Table 73. Toshiba Corporation Business Overview

    Table 74. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product

    Table 75. Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 76. Toshiba Corporation Recent Development

    Table 77. Fujifilm Corporation Company Detail

    Table 78. Fujifilm Corporation Business Overview

    Table 79. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product

    Table 80. Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 81. Fujifilm Corporation Recent Development

    Table 82. Shimadzu Corporation Company Detail

    Table 83. Shimadzu Corporation Business Overview

    Table 84. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product

    Table 85. Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 86. Shimadzu Corporation Recent Development

    Table 87. Merck & Co. Company Detail

    Table 88. Merck & Co. Business Overview

    Table 89. Merck & Co. Brain Tumor Diagnosis and Therapeutics Product

    Table 90. Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 91. Merck & Co. Recent Development

    Table 92. AstraZeneca Company Detail

    Table 93. AstraZeneca Business Overview

    Table 94. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product

    Table 95. AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 96. AstraZeneca Recent Development

    Table 97. Bristol Myer Squibb Company Detail

    Table 98. Bristol Myer Squibb Business Overview

    Table 99. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product

    Table 100. Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 101. Bristol Myer Squibb Recent Development

    Table 102. Novartis Company Detail

    Table 103. Novartis Business Overview

    Table 104. Novartis Brain Tumor Diagnosis and Therapeutics Product

    Table 105. Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 106. Novartis Recent Development

    Table 107. Roche Diagnostics Company Detail

    Table 108. Roche Diagnostics Business Overview

    Table 109. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product

    Table 110. Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2018-2023) & (US$ Million)

    Table 111. Roche Diagnostics Recent Development

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Brain Tumor Diagnosis and Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. MRI Features

    Figure 4. CT Scan Features

    Figure 5. Tissue Sampling Features

    Figure 6. PET-CT Scan Features

    Figure 7. Cerebral Arteriogram Features

    Figure 8. Lumbar Puncture Features

    Figure 9. Molecular Testing Features

    Figure 10. EEG Features

    Figure 11. Global Brain Tumor Diagnosis and Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 12. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application: 2022 VS 2029

    Figure 13. Surgery Case Studies

    Figure 14. Radiation Therapy Case Studies

    Figure 15. Chemotherapy Case Studies

    Figure 16. Immunotherapy Case Studies

    Figure 17. Targeted Therapy Case Studies

    Figure 18. Brain Tumor Diagnosis and Therapeutics Report Years Considered

    Figure 19. Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 20. Global Brain Tumor Diagnosis and Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 21. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region: 2022 VS 2029

    Figure 22. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players in 2022

    Figure 23. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2022)

    Figure 24. The Top 10 and 5 Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2022

    Figure 25. North America Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. North America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2018-2029)

    Figure 27. United States Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Canada Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Europe Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Country (2018-2029)

    Figure 31. Germany Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. France Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. U.K. Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Italy Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Russia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Nordic Countries Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Asia-Pacific Brain Tumor Diagnosis and Therapeutics Market Share by Region (2018-2029)

    Figure 39. China Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Japan Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. South Korea Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. India Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Australia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Latin America Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2018-2029)

    Figure 47. Mexico Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Brazil Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Brain Tumor Diagnosis and Therapeutics Market Share by Country (2018-2029)

    Figure 51. Turkey Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 53. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 54. Hitachi Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 55. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 56. Siemens Healthineers Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 57. Toshiba Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 58. Fujifilm Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 59. Shimadzu Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 60. Merck & Co. Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 61. AstraZeneca Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 62. Bristol Myer Squibb Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 63. Novartis Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 64. Roche Diagnostics Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2018-2023)

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed